Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Marketing Long-Term Efficacy and Safety Study of ReQuip Tablets in Parkinson's Disease
jRCT1080220387Phase 4
- Sponsor
- GSK
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropinirole in Parkinson's disease (PD) and parkinsonism, sponsored by GSK.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)parkinsonism
Beyond the preview
Go deeper on jRCT1080220387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220387.